[144] Lincoln National Corp. SEC Filing
Rhea-AI Filing Summary
Form 144 filing for Lincoln National Corp. (LNC) reports a proposed sale of 6,362 common shares held at UBS Financial Services with an aggregate market value of $260,020.34, and an approximate sale date of 08/15/2025 on the NYSE. The shares were acquired the same day, 08/15/2025, through an ESOP exercise from Lincoln National Corp., and payment was wired. The filing also discloses a prior sale by Brian Kroll of 10,075 common shares on 05/29/2025 generating gross proceeds of $333,483. The filer certifies no undisclosed material adverse information and includes standard Rule 144 representations.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 sale by an insider; amounts are modest relative to large-cap market caps and likely non-material.
The filing shows a proposed sale of 6,362 shares valued at $260k and a prior sale of 10,075 shares for $333k. The acquisition via ESOP exercise on the same date and sale through UBS indicates internal compensation shares being monetized under Rule 144. There is no disclosure of material non-public information and no unusual restrictions noted. For most investors, these transactions represent standard insider liquidity rather than a change in corporate operations or financial condition.
TL;DR: Disclosure complies with Rule 144 formalities; representation about lack of undisclosed material information is included.
The form properly identifies the broker, class, share counts, and sale timing. The statement asserting the signer is unaware of undisclosed material adverse information aligns with required certifications. The filing notes an ESOP exercise as the acquisition source and a wire payment, which clarifies the economic provenance of the shares. No governance irregularities or compliance issues are evident from the provided text.